Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.

C-K Hui; W W W Cheung; W-Y Au; A K W Lie; H-Y Zhang; Y-H Yueng; B C Y Wong; N Leung; Y-L Kwong; R Liang

doi:10.1136/gut.2005.070763

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.

Identifier:nobleid.org/w1/20260515/C2AF93FC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C2AF93FC.svg?ark=w1%2F20260515%2FC2AF93FC)](https://nobleid.org/work/w1/20260515/C2AF93FC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.

Identifier:nobleid.org/w1/20260515/C2AF93FC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C2AF93FC.svg?ark=w1%2F20260515%2FC2AF93FC)](https://nobleid.org/work/w1/20260515/C2AF93FC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work